Yttrium Y 90 Ibritumomab Tiuxetan at Medical Drugs Glossary
What is Yttrium Y 90 Ibritumomab Tiuxetan? An anticancer drug that is a combination of a monoclonal antibody and a radioisotope (yttrium-90). Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells. Also called IDEC-Y2B8 monoclonal antibody.Medical Term & Definition Added By: Andrew
The Yttrium Y 90 Ibritumomab Tiuxetan definition has been viewed 342 Time(s)!
Send To Friends!
If you'd like to send the Yttrium Y 90 Ibritumomab Tiuxetan definition to yourself or to your friends/colleagues, just enter the e-mail addresses in the boxes below -We hope you now understand the meaning of Yttrium Y 90 Ibritumomab Tiuxetan. If you need any more information on this term, please don't hesitate to contact us.
Other Similar Drugs Terms:
Prescription Drugs Term Lentivirus is A retrovirus utilized for gene therapy vectors.Prescription Drugs Term symptom is An indication that a person has a condition or disease. Some examples of symptoms are headache, fever, fatigue, nausea, vomiting, and pain.
Prescription Drugs Term filler is An inactive substance used to make a product bigger or easier to handle. For example, fillers are often used to make pills or capsules because the amount of active drug is too small to be handled conveniently.
Prescription Drugs Term granulocyte (GRAN-yoo-lo-site) is A type of white blood cell that fights bacterial infection. Neutrophils, eosinophils, and basophils are granulocytes.
Prescription Drugs Term Cold-shock protein is A protein expressed at low temperatures that protects cell components. For example, CspA, a cold-shock protein of E. coli, binds RNA and prevents secondary structure formation.